Originally published on www.healthimpactnews.com Glenn Greenwald, a journalist, constitutional lawyer, commentator, and author of three New York Times best-selling books on politics and law, has been working with NBC News in publishing a series of articles on how covert government agents infiltrate the Internet to “manipulate, deceive, and destroy reputations.” read more
Category Archives: Uncategorized
The ancestral environment shapes antiviral CD8+ T cell responses across generations.
PMID: iScience. 2019 Sep 14 ;20:168-183. Epub 2019 Sep 14. PMID: 31569050 Abstract Title: The Ancestral Environment Shapes Antiviral CD8T cell Responses across Generations. Abstract: Recent studies have linked health fates of children to environmental exposures of their great grandparents. However, few studies have considered whether ancestral exposures influence immune function across generations. Here, we report …
Spontaneous regression of occult breast cancer with axillary lymph node metastasis.
PMID: Int J Surg Case Rep. 2019 Sep 20 ;63:75-79. Epub 2019 Sep 20. PMID: 31569070 Abstract Title: Spontaneous regression of occult breast cancer with axillary lymph node metastasis: A case report. Abstract: INTRODUCTION: Spontaneous regression of a malignant tumor is defined as"the partial or complete disappearance of a malignant tumor in the absence of …
BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages.
PMID: Phytomedicine. 2018 Mar 15 ;42:226-232. Epub 2018 Mar 19. PMID: 29655690 Abstract Title: BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. Abstract: BACKGROUND: Bitter melon (Momordica charantia) is a commonly used food crop for management of a variety of diseases most notably for control of diabetes, a …
Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes.
PMID: Carbohydr Polym. 2018 Dec 1 ;201:624-633. Epub 2018 Aug 27. PMID: 30241862 Abstract Title: Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats. Abstract: The influence of Lactobacillus plantarum-fermentation on the structure and anti-diabetic effects of Momordica charantia polysaccharides were evaluated. High-fat diet and streptozotocin-induced type 2 …
Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities.
PMID: Phytochemistry. 2019 Jan ;157:21-27. Epub 2018 Oct 22. PMID: 30352327 Abstract Title: Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities. Abstract: Momordica charantia L. (Cucurbitaceae) is a popular vegetable and traditional folk medicine, that has been used for hundreds of years. In this study, three undescribed …
M. charantia adjunct preparations improved glycemic control in T2DM patients.
PMID: J Ethnopharmacol. 2019 Mar 1 ;231:311-324. Epub 2018 Oct 30. PMID: 30385422 Abstract Title: Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. Abstract: ETHNOPHARMACOLOGICAL RELEVANCE: Momordica charantia Linnaeus (Cucurbitaceae) has been extensively used traditionally as food and herbal medicine for type 2 diabetes mellitus in Asia, …
Continue reading “M. charantia adjunct preparations improved glycemic control in T2DM patients.”
These results suggest that M. charantia polysaccharide chromium might be an excellent candidate hypoglycemic agent for the prevention of diabetes.
PMID: Int J Biol Macromol. 2019 Feb 1 ;122:619-627. Epub 2018 Nov 2. PMID: 30391593 Abstract Title: Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes. Abstract: Polysaccharides comprise the major bioactive components in Momordica charantia L. We here synthesized and characterized a novel M. charantia …
Dietary bitter melon can attenuate the development of atherosclerosis.
PMID: Lipids Health Dis. 2018 Nov 6 ;17(1):251. Epub 2018 Nov 6. PMID: 30400958 Abstract Title: Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation. Abstract: BACKGROUND: Bitter melon (BM, Momordica charantia) has been accepted as an effective complementary treatment of metabolic disorders such as diabetes, hypertension, dyslipidemia …
Continue reading “Dietary bitter melon can attenuate the development of atherosclerosis.”
Momordicinin showed potent α-amylase inhibitory activity.
PMID: Nat Prod Res. 2019 Jul 2:1-3. Epub 2019 Jul 2. PMID: 31264459 Abstract Title: Isolation, characterisation and investigation ofantidiabetic and antioxidant activity of phytoconstituents from fruit ofLinn. Abstract: The dry powder of MC fruits was extracted by maceration, ultrasonication, liquid-liquid partition and soxhlation. Theantidiabetic and antioxidant assays were used to screen extracts and fractions. …
Continue reading “Momordicinin showed potent α-amylase inhibitory activity.”
Health Time 